Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Huttunen

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
Chemico-Biological Interactions|February 20, 2018
Sulfenamide and sulfonamide derivatives of metformin can exert anticoagulant and profibrinolytic propertiesMagdalena Markowicz-Piasecka, Kristiina M Huttunen, Łukasz Mateusiak, et al.
European Journal of Pharmacology|June 14, 2017
New prodrugs of metformin do not influence the overall haemostasis potential and integrity of the erythrocyte membraneMagdalena Markowicz-Piasecka, Joanna Sikora, Łukasz Mateusiak, et al.
Oxidative Medicine and Cellular Longevity|August 4, 2017
Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase ActivityMagdalena Markowicz-Piasecka, Joanna Sikora, Łukasz Mateusiak, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2025
Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a reviewMagdalena Markowicz-Piasecka, Zuzanna Miłkowska, Santosh Kumar Adla, et al.
Tissue Antigens|March 24, 1998
Association between HLA-A1 allele and schizophrenia gene(s) in patients refractory to conventional neuroleptics but responsive to clozapine medicationL Lahdelma, A Ahokas, L C Andersson, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2018
Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrugNikki A Thiele, Jussi Kärkkäinen, Kenneth B Sloan, et al.
Journal of Pharmaceutical Sciences|June 1, 2012
In vitro and in vivo evaluation of a sulfenamide prodrug of basic metforminKristiina M Huttunen, Jukka Leppänen, Jouko Vepsäläinen, et al.
Biochemical Pharmacology|August 17, 2023
Metformin derivatives - Researchers' friends or foes?Sema Tuna Torunoglu, Agnieszka Zajda, Janne Tampio, et al.
Current Pharmaceutical Design|December 3, 2016
Is Metformin a Perfect Drug? Updates in Pharmacokinetics and PharmacodynamicsMagdalena Markowicz-Piasecka, Kristiina M Huttunen, Lukasz Mateusiak, et al.
Experimental Dermatology|August 19, 2000
Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic woundsM Huttunen, M L Aalto, R J Harvima, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Chemico-Biological Interactions|February 20, 2018
Sulfenamide and sulfonamide derivatives of metformin can exert anticoagulant and profibrinolytic propertiesMagdalena Markowicz-Piasecka, Kristiina M Huttunen, Łukasz Mateusiak, et al.
European Journal of Pharmacology|June 14, 2017
New prodrugs of metformin do not influence the overall haemostasis potential and integrity of the erythrocyte membraneMagdalena Markowicz-Piasecka, Joanna Sikora, Łukasz Mateusiak, et al.
Oxidative Medicine and Cellular Longevity|August 4, 2017
Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase ActivityMagdalena Markowicz-Piasecka, Joanna Sikora, Łukasz Mateusiak, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2025
Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a reviewMagdalena Markowicz-Piasecka, Zuzanna Miłkowska, Santosh Kumar Adla, et al.
Tissue Antigens|March 24, 1998
Association between HLA-A1 allele and schizophrenia gene(s) in patients refractory to conventional neuroleptics but responsive to clozapine medicationL Lahdelma, A Ahokas, L C Andersson, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2018
Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrugNikki A Thiele, Jussi Kärkkäinen, Kenneth B Sloan, et al.
Journal of Pharmaceutical Sciences|June 1, 2012
In vitro and in vivo evaluation of a sulfenamide prodrug of basic metforminKristiina M Huttunen, Jukka Leppänen, Jouko Vepsäläinen, et al.
Biochemical Pharmacology|August 17, 2023
Metformin derivatives - Researchers' friends or foes?Sema Tuna Torunoglu, Agnieszka Zajda, Janne Tampio, et al.
Current Pharmaceutical Design|December 3, 2016
Is Metformin a Perfect Drug? Updates in Pharmacokinetics and PharmacodynamicsMagdalena Markowicz-Piasecka, Kristiina M Huttunen, Lukasz Mateusiak, et al.
Experimental Dermatology|August 19, 2000
Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic woundsM Huttunen, M L Aalto, R J Harvima, et al.
Pageof 16